ResMed (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $191.26 +1.49%
Revenue Growth %: +13.1%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +13.1%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.68, $0.01 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $453.9 million versus the consensus estimate of $455.88 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Nike names former Pfizer CFO David Denton as new finance chief
- ResMed (RMD) PT Lowered to $266 at KeyBanc
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
